These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 27499825)
21. Potential host-related risk factors for recurrent urinary tract infection in Saudi women of childbearing age. Ahmed AF; Solyman AA; Kamal SM Int Urogynecol J; 2016 Aug; 27(8):1245-53. PubMed ID: 26872648 [TBL] [Abstract][Full Text] [Related]
22. Epidemiology and microbiology of recurrent UTI in women in the community in Oxfordshire, UK. Vazquez-Montes MDLA; Fanshawe TR; Stoesser N; Walker AS; Butler C; Hayward G JAC Antimicrob Resist; 2024 Feb; 6(1):dlad156. PubMed ID: 38204597 [TBL] [Abstract][Full Text] [Related]
24. What is the Cause of Recurrent Urinary Tract Infection? Contemporary Microscopic Concepts of Pathophysiology. Kim A; Ahn J; Choi WS; Park HK; Kim S; Paick SH; Kim HG Int Neurourol J; 2021 Sep; 25(3):192-201. PubMed ID: 34044483 [TBL] [Abstract][Full Text] [Related]
25. Fecal Microbiota Transfer for Clostridium difficile Infection and Its Effects on Recurrent Urinary Tract Infection. Wood N; Propst K; Yao M; Ferrando CA Urogynecology (Phila); 2023 Oct; 29(10):814-826. PubMed ID: 36946907 [TBL] [Abstract][Full Text] [Related]
26. Prospective cohort study of microbial and inflammatory events immediately preceding Escherichia coli recurrent urinary tract infection in women. Czaja CA; Stamm WE; Stapleton AE; Roberts PL; Hawn TR; Scholes D; Samadpour M; Hultgren SJ; Hooton TM J Infect Dis; 2009 Aug; 200(4):528-36. PubMed ID: 19586416 [TBL] [Abstract][Full Text] [Related]
28. Evaluation of systemic estrogen for preventing urinary tract infections in postmenopausal women. Fox KA; Lokken EM; Reed SD; Rahn DD Menopause; 2021 May; 28(7):836-844. PubMed ID: 33973539 [TBL] [Abstract][Full Text] [Related]
29. ALternatives To prophylactic Antibiotics for the treatment of Recurrent urinary tract infection in women (ALTAR): study protocol for a multicentre, pragmatic, patient-randomised, non-inferiority trial. Forbes R; Ali A; Abouhajar A; Brennand C; Brown H; Carnell S; Chadwick T; Eardley I; Lecouturier J; Mossop H; Pearce I; Pickard R; Thiruchelvam N; Walton K; Wilkinson J; Harding C Trials; 2018 Nov; 19(1):616. PubMed ID: 30413181 [TBL] [Abstract][Full Text] [Related]
30. Recurrent Hidad S; van der Putten B; van Houdt R; Schneeberger C; Kuil SD Antibiotics (Basel); 2022 Nov; 11(11):. PubMed ID: 36421283 [TBL] [Abstract][Full Text] [Related]
31. Update on Associated Risk Factors, Diagnosis, and Management of Recurrent Urinary Tract Infections in Children. Khan A; Jhaveri R; Seed PC; Arshad M J Pediatric Infect Dis Soc; 2019 May; 8(2):152-159. PubMed ID: 30053044 [TBL] [Abstract][Full Text] [Related]
32. Factors associated with recurrent urinary tract infections in spinal cord injured patients who use intermittent catheterization. Everett RG; Charles DK; Foss HE; O'Connor RC; Guralnick ML Can J Urol; 2021 Dec; 28(6):10920-10928. PubMed ID: 34895397 [TBL] [Abstract][Full Text] [Related]
33. Definition of Recurrent Urinary Tract Infections in Women: Which One to Adopt? Malik RD; Wu YR; Zimmern PE Female Pelvic Med Reconstr Surg; 2018; 24(6):424-429. PubMed ID: 29135809 [TBL] [Abstract][Full Text] [Related]
34. [Approach to recurrent urinary tract infections in women]. Matuszkiewicz-Rowińska J; Kościelska M Wiad Lek; 2017; 70(6 pt 2):1185-1188. PubMed ID: 29533910 [TBL] [Abstract][Full Text] [Related]
35. Outpatient prescribing and prophylactic antibiotic use for recurrent urinary tract infections in British Columbia, Canada. Saatchi A; Yoo JW; Marra F Can Urol Assoc J; 2021 Dec; 15(12):397-404. PubMed ID: 34171208 [TBL] [Abstract][Full Text] [Related]
36. Intracellular uropathogenic Escherichia coli are undetectable in urinary bladders after oral mecillinam treatment: An experimental study in a pig model of cystitis. Stærk K; Grønnemose RB; Palarasah Y; Lund L; Andersen TE Microb Pathog; 2022 Dec; 173(Pt A):105817. PubMed ID: 36244593 [TBL] [Abstract][Full Text] [Related]
38. Oestrogens for preventing recurrent urinary tract infection in postmenopausal women. Perrotta C; Aznar M; Mejia R; Albert X; Ng CW Cochrane Database Syst Rev; 2008 Apr; (2):CD005131. PubMed ID: 18425910 [TBL] [Abstract][Full Text] [Related]
39. Standardised Chinese herbal treatment delivered by GPs compared with individualised treatment administered by practitioners of Chinese herbal medicine for women with recurrent urinary tract infections (RUTI): study protocol for a randomised controlled trial. Flower A; Harman K; Lewith G; Moore M; Bishop FL; Stuart B; Lampert N Trials; 2016 Jul; 17():358. PubMed ID: 27460108 [TBL] [Abstract][Full Text] [Related]
40. Clinical efficacy of Tailin formulation combined with continuous low-dose antimicrobial therapy for recurrent urinary tract infection: study protocol for a multicenter, double-blind, randomized, controlled clinical trial. Li T; Xu Y; Gong X Trials; 2021 Dec; 22(1):901. PubMed ID: 34895307 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]